Skip to content

Ellipsys Fistula for Hemodialysis Access

Ellipsys Percutaneous Arteriovenous Fistula for Hemodialysis Access

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03828253
Enrollment
100
Registered
2019-02-04
Start date
2018-08-27
Completion date
2021-08-27
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ESRD

Brief summary

To report the outcomes of patients having percutaneous proximal radial artery fistula creation.

Detailed description

The study would like to enroll up to 100 patients without age, gender-based, race and ethnicity enrollment restrictions for adults over 18 years of age. Women of child bearing potential are not excluded. If a pregnant patient required, an arteriovenous fistula for hemodialysis an Ellipsys® fistula would be an option. The Investigator would like to consent previous Ellipsys® patients with appropriate medical records so that the Investigator may capture participants data for outcomes reporting.

Interventions

None listed

Sponsors

Richmond Vascular Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient age \> 18 years or older * Diagnosed with ESRD or chronic kidney disease requiring dialysis or anticipating start of dialysis * Adjacent vein diameter of \> 2.0 mm at target anastomosis site and confirmed clinically significant outflow * Arterial lumen diameter of \> 2.0 mm at target anastomosis site * Adequate collateral arterial perfusion: Barbeau test grade A through C * Radial artery -adjacent vein proximity \< 1.5 mm measured lumen edge-to-lumen edge via ultrasound

Exclusion criteria

* Target vessel that are \< 2mm is diameter * Distance between the target artery and vein \> 1.5 mm * Edema of the upper extremity on the ipsilateral side * Barbeau test grade D

Design outcomes

Primary

MeasureTime frameDescription
Blood flow Volume90 daysBrachial Artery flow volume of 500ml as measured on Ultrasound Duplex

Countries

United States

Contacts

Primary ContactTricia Eichenlaub, RN
Teichenlaub@Richmondvascularcenter.com804-864-8346
Backup ContactBrittani Lewis
Blewis@Richmondvascularcenter.com804-864-8346

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026